Ultrasound

MicroFlow (MFI) and MicroFlow-HD (MFI-HD) imaging mode

Detect low-velocity micro-vessel anatomy in tissue without using contrast

MicroFlow Imaging (MFI) detects slow and weak blood flow anatomy in tissue. It maintains a high frame rate and excellent 2D image quality while applying artifact reduction techniques. 2D image subtraction, 2D blending and side-by-side display options offer versatility in visualization.  

MFI-HD offers twice the sensitivity and resolution of MFI in assessing blood flow1. MFI HD is well-suited for studies requiring high resolution and sensitivity, including renal/abdominal, breast, MSK, small parts, CEUS, and OB/GYN exams.

Philips mL26-8

Featured product

MFI Image Gallery

Features

Spatial temporal clutter filter

Spatial-temporal clutter filter

 

MFI’s novel spatial-temporal filter analyzes Doppler data, evaluating signal characteristics from both a spatial and temporal dimension in order to distinguish the flow signals from the tissue clutter signals. In this manner, MFI can detect the lowest velocity blood flow, which microvascular vessels typically exhibit, and remove distracting tissue clutter.

Vessel enhancement algorithm

Vessel enhancement algorithm

 

The vessel enhancement algorithm in MFI-HD reduces noise and enhances detected vessels1 without introducing blurring often seen with more traditional image processing techniques. This vessel enhancement combines with acoustic transmits designed to optimize flow sensitivity  and spatial resolution to improve visualization with high spatial resolution.

Four display modes

Four display modes

 

MFI HD features four display modes based on if tissue subtraction and echo-flow compare are used, allowing customization of images. When tissue subtraction is on, MFI is focuses on displaying only the flow information, and therefore this provides the most sensitive display method. When tissue subtraction is off, MFI utilizes a tissue-flow arbitration algorithm to seamlessly blend flow with tissue information in a smooth and natural manner, therefore providing anatomical context to the visualized flow. It has the additional benefit of further tissue artifact suppression.

Ovarian blood flow with MFI

Visualize blood flow in fetal, placental, uterine and ovarian vasculature

 

MFI and MFI-HD help in visualizing and detecting blood flow in fetal, placental, uterine and ovarian vasculature. In a study of ovarian perfusion visualization using endocavity transducers, MFI enhanced ovarian perfusion visualization in 100% of cases.* 85% of users surveyed stated that MFI, with its ultrasensitive blood flow imaging, enhances their diagnostic confidence.**

MFI and MFI HD is available on these transducers, C5-1, C9-2, L12-3, C8-5 and eL18-4

  •  

    eL18-4 Transducer  

    Learn more about the Philips eL18-4 ultra-broadband linear array transducer with PureWave crystal technology in the specification table below.

    453561780782
  •  

    C5-1  

    Learn more about the Philips C5-1 broadband curved array transducer with PureWave crystal technology in the specification table below.

    989605412041
  •  

    C9-2  

    Learn more about the Philips C9-2 broadband curved array transducer with PureWave crystal technology in the specification table below.

    989605391091
  •  

    L12-3  

    Learn more about the Philips L12-3 broadband linear array transducer in the specification table below.

    989605412071
  •  

    C8-5  

    Learn more about the Philips C8-5 broadband curved array transducer in the specification table below.

    989605391921

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

Footnotes
 

1 Internal measured comparison on standards MFI to MFI HD using clinical targets and standard measurement methodology. Not available on Affiniti systems.

*Based on a sample size of 21 users.

**Based on a sample size of 20 users.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.